The Relationship between Leptin, the Leptin Receptor and FGFR1 in Primary Human Breast Tumors
Open Access
- 1 October 2020
- Vol. 9 (10), 2224
- https://doi.org/10.3390/cells9102224
Abstract
Obesity is associated with increased breast cancer risk and poorer cancer outcomes; however, the precise etiology of these observations has not been fully identified. Our previous research suggests that adipose tissue-derived fibroblast growth factor-2 (FGF2) promotes the malignant transformation of epithelial cells through the activation of fibroblast growth factor receptor-1 (FGFR1). FGF2 is increased in the context of obesity, and increased sera levels have been associated with endocrine-resistant breast cancer. Leptin is a marker of obesity and promotes breast carcinogenesis through several mechanisms. In this study, we leverage public gene expression datasets to evaluate the associations between FGFR1, leptin, and the leptin receptor (LepR) in breast cancer. We show a positive association between FGFR1 and leptin protein copy number in primary breast tumors. These observations coincided with a positive association between Janus kinase 2 (Jak2) mRNA with both leptin receptor (LepR) mRNA and FGFR1 mRNA. Moreover, two separate Jak2 inhibitors attenuated both leptin+FGF2-stimulated and mouse adipose tissue-stimulated MCF-10A transformation. These results demonstrate how elevated sera FGF2 and leptin in obese patients may promote cancer progression in tumors that express elevated FGFR1 and LepR through Jak2 signaling. Therefore, Jak2 is a potential therapeutic target for FGFR1 amplified breast cancer, especially in the context of obesity.Keywords
Funding Information
- National Institutes of Health (R01GM134307, R01ES030695)
This publication has 40 references indexed in Scilit:
- Fibroblast Growth Factor Receptor Signaling Is Essential for Normal Mammary Gland Development and Stem Cell FunctionThe International Journal of Cell Cloning, 2012
- Global obesity: trends, risk factors and policy implicationsNature Reviews Endocrinology, 2012
- Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysisBreast Cancer Research and Treatment, 2012
- Body Size, Physical Activity, and Risk of Triple-Negative and Estrogen Receptor–Positive Breast CancerCancer Epidemiology, Biomarkers & Prevention, 2011
- Body Fat Distribution and Risk of Premenopausal Breast Cancer in the Nurses' Health Study IIJNCI Journal of the National Cancer Institute, 2010
- Leptin upregulates VEGF in breast cancer via canonic and non-canonical signalling pathways and NFκB/HIF-1α activationCellular Signalling, 2010
- Epidemiology of basal-like breast cancerBreast Cancer Research and Treatment, 2007
- FGFR1 amplification in breast carcinomas: a chromogenic in situhybridisation analysisBreast Cancer Research, 2007
- Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer StudyJAMA, 2006
- Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. AdultsThe New England Journal of Medicine, 2003